Pancreatic Cancer Research

ResearcherJiangnan UniversityActive in the last 2 years

Zhiyuan Hua

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5056182216. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 3 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 6

  1. Retraction Note: Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway. First author DOI 10.1186/s12935-025-03710-4↗
  2. Exosomal SOX21-AS1 Regulates EREG by Sponging miR-451a and Promotes the Malignancy of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.95014↗
  3. Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway. First author DOI 10.1186/s12935-020-01288-7↗
  4. LncRNA UCA1 impacts cell proliferation, invasion, and migration of pancreatic cancer through regulating miR-96/FOXO3. Co-author DOI 10.1002/iub.1699↗
  5. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling. Co-author DOI 10.1002/jcp.26357↗
  6. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients. Last author DOI 10.1016/j.cca.2018.01.024↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongping Zhou · 6 shared papers, 2018–2025 · strength 0.86
  2. Tu Dai · 3 shared papers, 2020–2025 · strength 0.60
  3. Liying Wang · 3 shared papers, 2018–2025 · strength 0.47
  4. Yong Yan · 1 shared paper, 2024 · strength 0.21
  5. Bin Xu · 1 shared paper, 2024 · strength 0.21
  6. Fang‐Ming Chen · 1 shared paper, 2020 · strength 0.12
  7. Tu Dai · 1 shared paper, 2018 · strength 0.09
  8. Tu Dai · 1 shared paper, 2018 · strength 0.09
  9. Bo Chen · 1 shared paper, 2018 · strength 0.09
  10. Haixin Qian · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.